STOCK TITAN

Voyager Therapeutics (NASDAQ: VYGR) affiliate files to sell 9,406 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Voyager Therapeutics (VYGR) notice of proposed sale of 9,406 shares of common stock under Section 144, with the transaction dated 05/15/2026. The filing notes an option granted on 02/06/2026 and lists 60,421,287 shares outstanding as of 05/15/2026 as a context figure. The record shows a prior sale of 4,668 shares on 02/24/2026 generating $17,588.09 in proceeds.

Positive

  • None.

Negative

  • None.

Insights

Form 144 reports a proposed registered resale of shares by an affiliate under Rule 144.

The filing lists 9,406 shares proposed for sale on 05/15/2026, tied to an option granted 02/06/2026. It also records a prior disposition of 4,668 shares on 02/24/2026.

Rule 144 notices are administrative disclosures; the actual sale depends on broker execution and compliance with holding‑period and public information requirements. Subsequent filings will show completion or further dispositions.

Proposed resale 9,406 shares proposed sale date 05/15/2026
Prior sale 4,668 shares sold on 02/24/2026 for $17,588.09
Proceeds from prior sale $17,588.09 proceeds from 02/24/2026 disposition
Shares outstanding 60,421,287 shares as of 05/15/2026
Option grant date 02/06/2026 option granting the shares to be sold
Form 144 regulatory
"Common | Fidelity Brokerage Services LLC ... | 9406 | 05/15/2026"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Option Granted financial
"Securities To Be Sold ... Option Granted - 02/06/2026"
Issuer regulatory
"Securities To Be Sold ... Issuer ... 9406"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the VYGR Form 144 report?

It reports a proposed sale of 9,406 common shares on 05/15/2026. The notice ties the sale to an option granted 02/06/2026 and records a prior sale of 4,668 shares on 02/24/2026 that produced $17,588.09 in proceeds.

Who is the likely broker handling the transaction for VYGR?

Fidelity Brokerage Services LLC is listed as the broker/dealer for the transaction. The filing shows the broker at 900 Salem Street, Smithfield, RI, associated with the 9,406 shares and the 05/15/2026 transaction date.

What prior sales are disclosed in the VYGR excerpt?

A prior sale of 4,668 common shares on 02/24/2026 is disclosed. That disposition generated $17,588.09 in proceeds and is presented alongside the proposed resale dated 05/15/2026 in the filing excerpt.

How many VYGR shares were outstanding per the filing?

The filing lists 60,421,287 shares outstanding as of 05/15/2026. This figure appears in the securities information block and serves as a context number in the excerpt provided.